Related Experiment Video

Updated: Jul 10, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Rotavirus diarrhoea and future prospects for prevention

Linda Diggle1

  • 1Health and Social Services Department, States of Jersey, Jersey.

British Journal of Nursing (Mark Allen Publishing)
|November 21, 2007
PubMed

Insights

Rotavirus, a common cause of severe diarrhea in children, can be prevented with new vaccines. These vaccines offer hope for reducing illness and healthcare burdens associated with this contagious infection.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Rotavirus is a highly contagious pathogen responsible for severe gastroenteritis in young children globally.
  • While dehydration therapies mitigate mortality in developed nations like the UK, rotavirus infections still impose significant morbidity and economic costs.
  • The faecal-oral transmission route and high prevalence mean nearly all children contract rotavirus before age five.

Purpose of the Study:

  • To review the impact of rotavirus infections on child health and healthcare systems.
  • To discuss the management of rotavirus, focusing on dehydration prevention.
  • To introduce new-generation rotavirus vaccines as a preventive strategy.

Main Methods:

  • Literature review of rotavirus epidemiology and impact.
  • Analysis of current management strategies for rotavirus infections.
  • Overview of recently licensed rotavirus vaccines and their clinical trial data.

Main Results:

  • Rotavirus infection causes significant childhood illness, mortality in developing countries, and substantial healthcare burdens globally, including prolonged hospital stays due to nosocomial spread.
  • No specific antiviral treatments exist, making supportive care and dehydration prevention the cornerstone of management.
  • Two new rotavirus vaccines have been licensed after extensive clinical trials, demonstrating potential for disease prevention.

Conclusions:

  • New rotavirus vaccines represent a significant advancement in preventing severe rotavirus disease in children.
  • Vaccination can alleviate the burden on healthcare systems and reduce the impact of rotavirus on child health.
  • Further implementation of rotavirus vaccination is expected to improve pediatric health outcomes worldwide.

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...